Your browser doesn't support javascript.
loading
First-in-human phase I study of infusional and bolus schedules of Deflexifol, a novel 5-fluorouracil and leucovorin formulation, after failure of standard treatment.
Clingan, Philip R; Ackland, Stephen P; Brungs, Daniel; de Souza, Paul; Aghmesheh, Morteza; Garg, Madhu B; Ranson, Richard D; Parker, Suzanne; Jokela, Rebecca; Ranson, Marie.
Afiliação
  • Clingan PR; Southern Medical Day Care Centre, Wollongong, Australia.
  • Ackland SP; Illawarra Health and Medical Research Institute, Wollongong, Australia.
  • Brungs D; Calvary Mater Hospital/ HMRI, Newcastle, Australia.
  • de Souza P; Illawarra Health and Medical Research Institute, Wollongong, Australia.
  • Aghmesheh M; School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, Australia.
  • Garg MB; Western Sydney University School of Medicine, Sydney, Australia.
  • Ranson RD; Illawarra Health and Medical Research Institute, Wollongong, Australia.
  • Parker S; Illawarra Cancer Care Centre, Wollongong, Australia.
  • Jokela R; Calvary Mater Hospital/ HMRI, Newcastle, Australia.
  • Ranson M; FivepHusion Pty Ltd., Austinmer, NSW, Australia.
Asia Pac J Clin Oncol ; 15(3): 151-157, 2019 Jun.
Article em En | MEDLINE | ID: mdl-30843362
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article